Antibody maker Abpro to go public via SPAC deal

A Woburn biotech behind antibodies for Covid-19, cancer and eye disease is set to go public by reverse-merging with a special-purpose acquisition company, or SPAC.

Fischer Homes promotes Steve Whaley to senior vice president of corporate strategy

Queen’s Medical Center named best Hawaii hospital for 10th year

Health Connect South: Seven insights from this year’s conference

Biscuitville CEO Kathie Niven on expansion plans, potential new model

A Portland tea company grows up, makes itself a drink

Why the cost of your Thanksgiving dinner is down in 2023

Electronics provider Plug relocates to larger HQ

CRE Deal Makers: Chris Lowe, Samet Corp.

Antibody maker Abpro to go public via SPAC deal

Previous Historic house tops list of Triad's biggest home sales for the week of Sept. 15

Next She Sings Cafe to bring food, drinks and performances to Mayville

firststargroup

Kotek touts $500M Oregon housing plan at Leadership Summit

Retirement plans see boost as states mandate IRAs and tax credits lower costs

Norton Healthcare data breach affected more than 2 million people

Houston-based cell therapy company FibroBiologics files to go public

Suggested Posts

Women of Influence: Nina Morrison, Talking Rain

Laurel Communities proposes 26-townhouse project along Grandview Avenue on long-dormant site

Waterfront Village condo sells for $950,000 after 10 days on market

CVS says recent M&As will ‘unlock growth’ in value-based care

Phoenix Investors buys former Electrolux plant in St. Cloud

Restaurant Roundup: Shake Shack partners with Favor Delivery

MENU

FirstStar Group

More Stories

Banking Roundup: Citi refunds $335M… Banks plan buybacks after stress test

Previous Historic house tops list of Triad's biggest home sales for the week of Sept. 15

Next She Sings Cafe to bring food, drinks and performances to Mayville

firststargroup

Related Posts

Suggested Posts

MENU

FirstStar Group

More Stories